The abstract is read at the publisher; the summary is JClub's.
In 3,977 presumptive TB patients tested in two district hospitals in Ghana (2020–2024), overall GeneXpert MTB/RIF positivity was 11.6% (461/3977), with indeterminate rifampicin results reaching 9.3% of MTb-positive samples.
- Why it matters: Specimen quality and indeterminate rifampicin susceptibility can undermine first-line TB diagnosis, and Ghana’s program needs evidence to refine how sputum is collected and how indeterminate results are handled.
- What they did: The study retrospectively analyzed demographic data, sputum macroscopic appearance, and GeneXpert outcomes from samples collected at HopeXchange Medical Center (Kumasi) and Keta Municipal Hospital, using descriptive statistics and Fisher’s exact test.
- The result: Mucopurulent specimens had the highest positivity (25.4%) versus salivary specimens (4.0%), while blood-stained sputum (n=44) showed 15.9% positivity; indeterminate results at Kwadaso Municipal rose from 7.3% in 2021 to 28.6% in 2024.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.